CME: Challenging Case Studies: Percutaneous Coronary Interventions and Post-discharge Antithrombotic Management

Challenging Case Studies: Percutaneous Coronary Interventions and Post-discharge Antithrombotic Management

Challenging Case Studies: Percutaneous Coronary Interventions and Post-discharge Antithrombotic Management
RestartResume
Drs. Bhatt and Mehran discuss clinical cases and challenges that cardiologists face when caring for these complex cases.

Available credits: 0.25

Time to complete: 15 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Based on a live symposium held on April 26, 2018, this innovative, 15-minute, case-based CME activity features two prominent faculty covering important, timely clinical issues and recent data related to anticoagulation in patients after percutaneous coronary interventions.

  • Provider(s)/Educational Partner(s)

    Jointly provided by the Annenberg Center for Health Sciences at Eisenhower (www.annenberg.net) and Medtelligence in collaboration with Postgraduate Institute for Medicine.

    This activity is supported by an independent medical educational grant from Janssen Scientific Affairs, LLC.

  • Target Audience

    This activity has been designed to meet the educational needs of Interventional/Invasive Cardiologists, Cardiologists, Fellows, and other Healthcare Professionals involved in the care of patients with coronary artery disease.

  • Educational Objectives

    After completing this activity, the participant should be better able to:

    • Discuss the importance and key clinical issues of combining NOACs with antiplatelet agents in patients discharged after percutaneous coronary interventions
    • Utilize NOACs at the proper dose for patients with moderate or high risk of stroke and performing proper follow-up
  • Faculty

    Deepak L. Bhatt, MD, FSCAI, Chair
    Executive Director, Interventional Cardiovascular Programs
    Brigham and Women’s Hospital Heart & Vascular Center
    Professor, Harvard Medical School
    Boston, MA

    Roxana Mehran, MD, MSCAI
    Professor of Medicine (Cardiology) and Population Health Science and Policy
    Director of Interventional Cardiovascular Research and Clinical Trials
    Zena and Michael A. Weiner Cardiovascular Institute
    Icahn School of Medicine at Mount Sinai
    New York, NY

  • Accreditation and Credit Designation Statements

    Accreditation Statement

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Medtelligence. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

    Credit Designation

    The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Disclosure of Conflicts of Interest

    The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The Annenberg Center for Health Sciences at Eisenhower is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

    The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    • Dr. Bhatt: Contracted Research: Amarin, Amgen, AstraZeneca, Bristol-Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Ironwood, Ischemix, Lilly, Medtronic, Pfizer, Roche, Sanofi Aventis, The Medicines Company.
    • Dr. Mehran: Consulting Fees: Abbott, Boston Scientific, Medscape, Spectranetics, The Medicines Company, Abiomed; Contracted Research: AstraZeneca, Beth Israel Deaconess, BMS, CSL Behring, Eli Lilly/DSI, Medtronic, Novartis, OrbusNeich; Ownership Interest: Claret Medical, Elixir Medical; Other: Janssen, Oprey Medical (Executive committee).

    The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    The PIM planners and managers have nothing to report.

    Charles E. Willis, Director of Continuing Education from the Annenberg Center for Health Sciences at Eisenhower consults for Pfizer, Inc.; Amanda Sewell, MBA, Manager of Continuing Education and Alma Perez, Accreditation Specialist from the Annenberg Center for Health Sciences at Eisenhower, both have no relevant commercial relationships to disclose.

    The Medtelligence planners and managers, Ben Caref, PhD, and Pamela Clark, have nothing to disclose.

  • Method of Participation and Request for Credit

    There are no fees for participating and receiving CME credit for this activity. During the period June 29, 2018 through June 29, 2019, participants must read the learning objectives and faculty disclosures and study the educational activity. 

    If you wish to receive acknowledgment for completing this activity, complete the post-test and evaluation. Participants who successfully complete the activity and evaluation will have a statement of credit made available immediately.

    If you have any questions regarding the CME certification of this activity, please contact Postgraduate Institute for Medicine at: inquiries@pimed.com or (303) 799-1930.

  • Disclosure of Unlabeled Use

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

  • Disclaimer

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

Sign-up for the Prova Education newsletters.

Better education for a better you.

* Required
Optional
Register

Join Prova Education's community of learners. Registration is free and easy.

Register Now